![Mike Quirk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Mike Quirk worked as Director at AstraZeneca Pharmaceuticals LP from 2012 to 2014.
Dr. Quirk worked as Chief Scientific Officer at SAGE Therapeutics, Inc. from 2023 to 2025.
Dr. Quirk completed undergraduate and doctorate degrees at the Massachusetts Institute of Technology.
Eerdere bekende functies van Mike Quirk
| Bedrijven | Functie | Einde |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2025 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Directeur/Bestuurslid | 01-05-2014 |
Opleiding van Mike Quirk
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
49
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
